BEQAX
Price
$35.60
Change
-$0.07 (-0.20%)
Updated
Aug 7 closing price
Net Assets
1.74B
VSTSX
Price
$298.03
Change
-$0.27 (-0.09%)
Updated
Aug 7 closing price
Net Assets
1.91T
Interact to see
Advertisement

BEQAX vs VSTSX

Header iconBEQAX vs VSTSX Comparison
Open Charts BEQAX vs VSTSXBanner chart's image
American Century Equity Growth A
Price$35.60
Change-$0.07 (-0.20%)
VolumeN/A
Net Assets1.74B
Vanguard Total Stock Mkt Idx Instl Sel
Price$298.03
Change-$0.27 (-0.09%)
VolumeN/A
Net Assets1.91T
BEQAX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BEQAX vs. VSTSX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEQAX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. BEQAX (1.74B). VSTSX pays higher dividends than BEQAX: VSTSX (1.20) vs BEQAX (0.40). BEQAX was incepted earlier than VSTSX: BEQAX (28 years) vs VSTSX (9 years). BEQAX (0.91) is less costly to investors than VSTSX (0.01). BEQAX is a more actively managed with annual turnover of: 53.00 vs. VSTSX (2.00). BEQAX has a lower initial minimum investment than VSTSX: BEQAX (2500) vs VSTSX (5000000000). BEQAX (22.68) and VSTSX (21.80) have marching annual gain over last year. VSTSX return over 5 years is better than : 84.04 vs. BEQAX (13.30).
BEQAXVSTSXBEQAX / VSTSX
Total Expense Ratio0.910.019,100%
Annual Report Gross Expense Ratio0.910.019,100%
Fund Existence28 years9 years-
Gain YTD6.6937.46890%
Front Load6%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B1.91T0%
Annual Yield % from dividends0.401.2033%
Returns for 1 year22.6821.80104%
Returns for 3 years41.9450.2783%
Returns for 5 years13.3084.0416%
Returns for 10 years25.66N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOLN3.660.18
+5.32%
Molecular Partners AG
LYRA6.890.11
+1.62%
Lyra Therapeutics Inc
AACT11.39-0.02
-0.18%
Ares Acquisition Corp
IEX158.53-1.19
-0.75%
IDEX Corp
HCM16.31-1.61
-9.01%
HUTCHMED (China) Limited